Basal cell carcinoma of skin of trunk
ICD-10 C44.51 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of trunk.
Basal cell carcinoma (BCC) is the most common form of skin cancer, primarily arising from the basal cells in the epidermis. It is characterized by uncontrolled growth of these cells, often resulting from prolonged exposure to ultraviolet (UV) radiation from the sun. BCC typically presents as a pearly or waxy bump, a flat, flesh-colored lesion, or a scar-like area on the skin. The trunk, which includes the chest, abdomen, and back, is a common site for BCC due to sun exposure. Surgical excision is the primary treatment, aiming to achieve clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and location of the excised lesion, particularly in cosmetically sensitive areas. The prognosis for BCC is generally excellent, with a low risk of metastasis, but careful monitoring is essential to detect any new lesions or recurrences. Regular skin examinations and sun protection strategies are crucial for prevention.
Detailed descriptions of the lesion, including size, location, and histological type.
Diagnosis and treatment of BCC, Mohs micrographic surgery, and follow-up care.
Ensure clear documentation of margins and any reconstructive procedures performed.
Comprehensive treatment plans, including surgical and non-surgical interventions.
Management of advanced BCC cases and coordination of care with dermatology.
Document any systemic therapies or clinical trials if applicable.
Used when excising a BCC from the trunk.
Document size, location, and margins of the excised lesion.
Dermatology should ensure detailed operative notes.
The primary treatment for basal cell carcinoma is surgical excision, often with Mohs micrographic surgery for high-risk lesions to ensure clear margins.
